3 unknown. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 3 | 2 | Unknown 2 |
Follow Ventricular Remodeling: new trials by email Literature Review of Ventricular Remodeling trials Research Report on Ventricular Remodeling
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Glucocorticoid Therapy on Left Ventricular Remodelling in Acute Myocardial Infarction (RECONSIDER) Hydrocortisone, Placebo - ST-segment Elevation Myocardial Infarction, Left Ventricular Remodeling | Phase 2 / Phase 3 | Unknown | Iuliu Hatieganu University of Medicine and Pharmacy | 77 | 2018-03-08 | 2020-09-28 |
| Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation Sacubitril-Valsartan, Valsartan - Atrial Remodeling, Myocardial Dysfunction | Phase 2 | Unknown | Mark Ledwidge | 250 | 2015-12-16 | 2021-05-11 |
| Changes in Myocardial Biomechanics and Early Short-term Doxycycline Therapy in Patients With Primary Anterior STEMI Doxycycline, Standard care for STEMI - Vascular Diseases, Cardiovascular Diseases | Phase 2 / Phase 3 | Unknown | Russian Academy of Medical Sciences | 45 | 2014-02-01 | 2016-12-13 |
ST Elevation Myocardial Infarction (2) · Atrial Remodeling (1) · Cardiovascular Diseases (1) · Hypertension (1) · Myocarditis (1) · Myositis (1) · Vascular Diseases (1) · Ventricular Dysfunction (1) · Ventricular Dysfunction, Left (1)
Heart Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Cardiovascular Diseases (2) · Infarction (2) · Ischemia (2) · Myocardial Infarction (2) · Myocardial Ischemia (2) · Necrosis (2) · Vascular Diseases (2) · Cardiomyopathies (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1)
Doxycycline (1) · Hydrocortisone (1) · Sodium Chloride (1) · Standard of Care (1) · Valsartan (1) · sacubitril and valsartan sodium hydrate drug combination (1)
Iuliu Hatieganu University of Medicine and Pharmacy (1) · Mark Ledwidge (1) · Russian Academy of Medical Sciences (1)
Ireland (1) · Romania (1) · Russia (1)
Adrian Corneliu Iancu, M.D, Ph.D (1) · Fiona Ryan, Co-Investigator, PhD (1) · Vyacheslav Ryabov, MD,PhD (1)
2015 (1)